Loading …
Skip to content
BioBuzz BioBuzz

Biotech and Life Science News, Jobs, and Events for the BioHealth Capital Region

Primary Menu
  • Jobseeker
    • BioBuzz Featured Employers
      • American Gene Technologies
      • BioFactura
      • Emergent BioSolutions
      • Kite
    • Job Board
    • Biomanufacturing Jobs in Maryland
    • Career Resources
  • Employer
    • Become a Featured Employer
    • Post a Job
  • News
    • BioHealth Capital Region News
    • Philadelphia Biotech News
    • Capital Projects
    • Press Releases
  • Features
    • 5 Questions With…
    • In Conversation
    • People On The Move
    • Submit Your People On The Move
  • Events
    • Free Event Listing
  • Awards
    • 2021 Awards Winners
    • 2021 Awards Finalists
    • 2020 Awards Winners
    • 2020 Awards Finalists

Pain Management Company Virpax Sees Promise in Potential COVID-19 Antiviral OTC

Headshot of Anthony Mack
Published on : November 12, 2021November 12, 2021 Published by : Alex Keown

Philadelphia-based Virpax Pharmaceuticals has licensed an asset, AnQlar, that has potential to be an OTC treatment for COVID-19.

Tagged in : COVID19 Epilepsy Pain Management Philadelphia PTSD Virpax
Categorized in : Philadelphia News

Stay in the Loop!

* indicates required
View All Jobs Post a Job

Past Newsletter Issues

Upcoming Events

Jan 26
Featured Featured January 26 @ 9:00 AM - January 28 @ 5:00 PM

3-D Cell Culturing

Feb 7
Featured Featured February 7 @ 9:00 AM - February 11 @ 5:00 PM

RNA-Seq: Principles, Methods & Computational Analysis

Feb 22
Featured Featured February 22 @ 9:00 AM - February 23 @ 5:00 PM

R for Research Scientists

View Calendar

Categories

Annual Sponsors

Bio-Trac
CRB
Frederick Department of Economic Development
  • Online Community
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • Youtube

Made with ♥ in Baltimore

Terms & Conditions  Privacy Policy

© 2021 BioBuzz Media™